Cluster-aware target evidence
Cluster-aware ligand profiles preserve target-internal chemotype evidence and help prioritize candidate protein targets from local scaffold support.
PharmTAP web server
PharmTAP combines cluster-aware target evidence and molecular property prediction to support early pharmacology analysis, target prioritization and developability assessment from a single SMILES query.
Prediction services
Cluster-aware ligand profiles preserve target-internal chemotype evidence and help prioritize candidate protein targets from local scaffold support.
USRCAT adds a complementary three-dimensional shape-pharmacophore evidence axis to support scaffold hopping and low two-dimensional support scenarios.
ADMET prediction summarizes absorption, distribution, metabolism, excretion, toxicity and physicochemical endpoints for early developability assessment.
DMPNN models learn molecular graph representations and integrate descriptor information to support endpoint-level property prediction.